naphthalimides has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, RJ; Chen, TY; Kao, WT; Lin, KH; Liu, JW; Lu, WJ; Peng, HY; Shih, TL; Sun, YY; Wang, HH | 1 |
| Li, C; Liu, Y; Lu, L; Meng, WQ; Xue, YS; Zhang, L; Zhao, J; Zou, F | 1 |
| Carling, D; Gressens, P; Hagberg, H; Kichev, A; Leiper, FC; Rousset, CI; Thornton, C | 1 |
| Cary, RL; Novack, DV; Pritchard, ZJ; Sankar, U; Voor, MJ; Yang, C | 1 |
| Chen, J; Kim, DH; Larson, AC; Omary, RA | 1 |
| Chatsudthipong, V; Muanprasat, C; Pongkorpsakol, P; Satitsri, S; Srimanote, P | 1 |
| Bontempi, G; Bruyère, C; Darro, F; De Nève, N; Decaestecker, C; Dehoux, MJ; Dewelle, J; Haibe-Kains, B; Kiss, R; Mahieu, T; Mijatovic, T; Simon, G; van der Aar, E; Van Quaquebeke, E | 1 |
| Bae, S; Choi, JH; Choudhury, S; Kang, PM; Ke, Q; Koh, YY; Siu, PM | 1 |
| Alcala, MA; Bartlett, DL; Kwan, SY; Lang, M; Lee, YJ; Petoud, S; Shade, CM; Uh, H; Wang, M; Weber, SG | 1 |
| Appella, DH; Chen, Z; Huang, S; Liu, Y; Lou, G; Norton, JT; Wang, C; Witschi, MA; Xu, Q | 1 |
10 other study(ies) available for naphthalimides and Disease Models, Animal
| Article | Year |
|---|---|
A novel naphthalimide derivative reduces platelet activation and thrombus formation via suppressing GPVI.
Topics: Adenosine Triphosphate; Animals; Blood Platelets; Calcium; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Immunohistochemistry; Male; Mice; Microvessels; Molecular Structure; Naphthalimides; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Signal Transduction; Thrombosis | 2021 |
Selective detection of endogenous H₂S in living cells and the mouse hippocampus using a ratiometric fluorescent probe.
Topics: Animals; Carbamates; Cattle; Cystathionine beta-Synthase; Depression; Disease Models, Animal; Down-Regulation; Fluorescent Dyes; Gene Expression; Hippocampus; Humans; Hydrogen Sulfide; Limit of Detection; MCF-7 Cells; Mice; Molecular Probes; Naphthalimides; RNA, Messenger; Signal Transduction; Spectrometry, Fluorescence; Stress, Psychological | 2014 |
A dual role for AMP-activated protein kinase (AMPK) during neonatal hypoxic-ischaemic brain injury in mice.
Topics: AMP-Activated Protein Kinases; Animals; Animals, Newborn; Benzimidazoles; Brain; Cell Death; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Developmental; Glucose; Hypoxia; Hypoxia-Ischemia, Brain; Ionomycin; L-Lactate Dehydrogenase; Mice; Mice, Inbred C57BL; Naphthalimides; Neurons; Signal Transduction; Time Factors | 2015 |
Inhibition of CaMKK2 reverses age-associated decline in bone mass.
Topics: Animals; Benzimidazoles; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Compressive Strength; Disease Models, Animal; Enzyme Inhibitors; Femur; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalimides; Osteogenesis; Osteoporosis; X-Ray Microtomography | 2015 |
MRI visible drug eluting magnetic microspheres for transcatheter intra-arterial delivery to liver tumors.
Topics: Adenine; Alginates; Animals; Antineoplastic Agents; Disease Models, Animal; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Injections, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Naphthalimides; Organophosphonates; Rats | 2015 |
Pathophysiological mechanisms of diarrhea caused by the Vibrio cholerae O1 El Tor variant: an in vivo study in mice.
Topics: Animals; Bacterial Typing Techniques; Butyrates; Chloride Channels; Cholera; Cholera Toxin; Cyclooxygenase 2; Diarrhea; Dinoprostone; Disease Models, Animal; Enteritis; Genetic Variation; Genotype; Intestines; Mice; Mice, Inbred CFTR; Mice, Inbred ICR; Naphthalimides; Nitric Oxide Synthase Type II; Vibrio cholerae O1 | 2016 |
UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Chemokines, CXC; Disease Models, Animal; Humans; Kinetics; Male; Mice; Naphthalimides; Neoplasm Transplantation; Prostatic Neoplasms; Urea | 2008 |
Delayed activation of caspase-independent apoptosis during heart failure in transgenic mice overexpressing caspase inhibitor CrmA.
Topics: 1-Naphthylamine; Animals; Apoptosis; Apoptosis Inducing Factor; Caspase Inhibitors; Caspases; Disease Models, Animal; Doxorubicin; Heart Failure; Male; Mice; Mice, Transgenic; Mitochondria, Heart; Naphthalimides; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Serpins; Viral Proteins | 2010 |
Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.
Topics: 1-Naphthylamine; Animals; Catheterization; Cell Line, Tumor; Colorectal Neoplasms; Dendrimers; Diagnostic Imaging; Disease Models, Animal; Europium; Liver; Liver Neoplasms; Luminescence; Nanoparticles; Naphthalimides; Particle Size; Quinolones; Rats; Time Factors | 2011 |
Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancer.
Topics: Adenine; Animals; Antineoplastic Agents; Cell Line; Disease Models, Animal; Gene Expression Profiling; Humans; Liver Neoplasms, Experimental; Mice; Mice, Nude; Naphthalimides; Organophosphonates; Stomach Neoplasms; Transplantation, Heterologous | 2011 |